Cromwell flags fund restructure


Publicly-listed property and funds management group Cromwell has flagged the purchase of key property assets from its unlisted Cromwell Property Fund (CPF) to clear the way for a recommencement of distributions to unit-holders.
The company has announced to the Australian Securities Exchange (ASX) that it will be writing to investors to give them an update on a strategic review of the CPF, which while still incomplete would involve the sale by CPF of properties in the Melbourne CBD and in Canberra.
The company said the properties in question were 321 Exhibition Street in Melbourne and the Therapeutic Goods Administration (TGA) complex located at Symonston in Canberra.
It said its two-thirds interest in the TGA complex was expected to generate $25 million, while the Exhibition Street property was expected to bring in the order of $90.2 million.
Cromwell said the sale proceeds would be used to reduce gearing within the Cromwell Property Fund, including part of its loan from Cromwell Group.
The ASX announcement said there were numerous issues that needed to be resolved before the Cromwell boards would be able to make a final decision about recommending the transactions to security holders.
However, it noted that the proposed transactions, if concluded, would be expected to ensure a stabilisation of the fund and allow a recommencement of distributions to unit-holders.
Recommended for you
There is a gap in the market for Australian advisers to help individuals with succession planning as the country has been noted by Capital Group for being overly “hands off” around inheritances.
ASIC has cancelled the AFSL of an advice firm associated with Shield and First Guardian collapses, and permanently banned its responsible manager.
Having peaked at more than 40 per cent growth since the first M&A bid, Insignia Financial shares have returned to earth six months later as the company awaits a final decision from CC Capital.
Private market secondaries manager Coller Capital has unveiled a new education platform to improve advisers’ and investors’ understanding of secondaries.